lobbying_activities: 1982755

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1982755	119f8bc2-658c-4b99-a55e-ed33d83ab948	Q2	JEFFREY J. KIMBELL & ASSOCIATES, INC.	46038	BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.	2017	second_quarter	HCR	Issues related to drug importation, counterfeiting, biosimilar reimbursement, S. 934, FDA regulation of animal drugs and Synthetics Trafficking and Overdose Prevention Act of 2017.	HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE	40000		0	0	2017-07-03T13:02:57.253000-04:00